Comprehension for Breast Awareness, Dense Breast, and Hereditary Breast and/or Ovarian Cancer (HBOC) in participants of Breast Cancer Screening

Author:

Nakagomi Hiroshi1ORCID,Teramoto Katsuhiro1,Nakada Haruka1,Matsuda Kei1,Yoneyama Ryoko1,Kawai Chiemi1,Miura Yoshinari1,Kunugi Chiemi1,Hirose Junji1,Yoda Yoshioki1

Affiliation:

1. Yamanashi Koseiren Health Care Center

Abstract

Abstract

Background: It is important to promote breast awareness (BA) as an alternative to breast self-examination in order to improve the prognosis of breast cancer patients. Methods: We investigated the level of comprehension for BA among participants of the organized (n=7959) and the opportunistic (n=11541) breast cancer screening. In addition, we investigated the level of comprehension for dense breast (DB) and hereditary breast and/or ovarian cancer (HBOC) as knowledge necessary for optimal breast cancer screening. Results: The overall percentages of comprehension of BA, DB and HBOC were 24, 32, and 24%, respectively. The level of comprehension of BA, DB, and HBOC was lower among participants aged <49 years compared to those aged >50 years. First-time participants were less likely to be aware of BA, DB, and HBOC than those who had screening for the second time or more. On the other hand, there was no difference in the level of comprehension of BA between organized and opportunistic screening, but the level of awareness of BD and HBOC was significantly higher in participants of opportunistic screening. Conclusions: The level of comprehension for BA, DB and HBOC is still low in 2023. Our results indicates that screening is an important opportunity to educate something about the breast health literacy. We intend to conduct this survey and educational campaign over time to determine if those comprehension improve.

Publisher

Springer Science and Business Media LLC

Reference24 articles.

1. Current and future burden of breast cancer: Global statistics for 2020 and 2040;Arnold M;Breast,2022

2. ganjoho.jp (in Japanese) https://ganjoho.jp/reg_stat/statistics/stat/cancer/14_breast on June, 29, 2024.

3. WHO mortality database. malignant neoplasms. https://platform.who.int/mortality/themes/theme-details/topics/topic-details/MDB/malignant-neoplasms on June 29, 2024.

4. International comparison of trends in cancer mortality: Japan has fallen behind in screening-related cancers;Katanoda K;Jpn J Clin Oncol,2021

5. Worldwide comparison of cancer screening (in Japanese). https://www.mhlw.go.jp/content/10901000/001132584.pdf on June, 29, 2024.

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3